Shanghai Hile Bio-tech (603718) - Total Liabilities

Latest as of March 2026: CN¥312.90 Million CNY ≈ $45.79 Million USD

Based on the latest financial reports, Shanghai Hile Bio-tech (603718) has total liabilities worth CN¥312.90 Million CNY (≈ $45.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shanghai Hile Bio-tech - Total Liabilities Trend (2011–2025)

This chart illustrates how Shanghai Hile Bio-tech's total liabilities have evolved over time, based on quarterly financial data. See 603718 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Shanghai Hile Bio-tech Competitors by Total Liabilities

The table below lists competitors of Shanghai Hile Bio-tech ranked by their total liabilities.

Company	Country	Total Liabilities
Veedol Corporation Limited NSE:VEEDOL	India	Rs3.52 Billion
Xuchang Ketop Testing Research Ins SHE:003008	China	CN¥45.68 Million
Blue Foundry Bancorp NASDAQ:BLFY	USA	$1.84 Billion
NICE Holdings Co. Ltd KO:034310	Korea	₩2.28 Trillion
Real Matters Inc TO:REAL	Canada	CA$15.92 Million
K&F Growth Acquisition Corp. II Unit NASDAQ:KFIIU	USA	$10.15 Million
Chunbo Co. Ltd KQ:278280	Korea	₩360.74 Billion
Te Chang Construction Co Ltd TWO:5511	Taiwan	NT$7.01 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Shanghai Hile Bio-tech's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Hile Bio-tech market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.27	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Hile Bio-tech's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Hile Bio-tech (2011–2025)

The table below shows the annual total liabilities of Shanghai Hile Bio-tech from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥229.14 Million ≈ $33.53 Million	+85.32%
2024-12-31	CN¥123.65 Million ≈ $18.09 Million	-74.40%
2023-12-31	CN¥482.96 Million ≈ $70.67 Million	+19.77%
2022-12-31	CN¥403.25 Million ≈ $59.01 Million	-52.94%
2021-12-31	CN¥856.90 Million ≈ $125.39 Million	+3.92%
2020-12-31	CN¥824.54 Million ≈ $120.66 Million	+16.34%
2019-12-31	CN¥708.72 Million ≈ $103.71 Million	-1.95%
2018-12-31	CN¥722.81 Million ≈ $105.77 Million	+37.20%
2017-12-31	CN¥526.83 Million ≈ $77.09 Million	+11.02%
2016-12-31	CN¥474.55 Million ≈ $69.44 Million	+71.31%
2015-12-31	CN¥277.01 Million ≈ $40.54 Million	+188.62%
2014-12-31	CN¥95.98 Million ≈ $14.04 Million	-4.19%
2013-12-31	CN¥100.17 Million ≈ $14.66 Million	+7.97%
2012-12-31	CN¥92.78 Million ≈ $13.58 Million	-5.61%
2011-12-31	CN¥98.29 Million ≈ $14.38 Million	--

About Shanghai Hile Bio-tech

SHG:603718 China Biotechnology

Market Cap

$274.74 Million

CN¥1.88 Billion CNY

Market Cap Rank

#15343 Global

#4512 in China

Share Price

CN¥2.88

Change (1 day)

-3.68%

52-Week Range

CN¥2.88 - CN¥7.67

All Time High

CN¥51.09